key: cord-0698086-waoe49em authors: Pigliacelli, Flavia; Pacifico, Alessia; Mariano, Maria; D’Arino, Andrea; Cristaudo, Antonio; Iacovelli, Paolo title: Morphea induced by SARS‐CoV‐2 infection: A case report date: 2021-11-15 journal: Int J Dermatol DOI: 10.1111/ijd.15983 sha: 44c1d8e11b9912312bd5aa7370a4879d640ee0d2 doc_id: 698086 cord_uid: waoe49em nan The widespread diffusion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the coronavirus family responsible for Coronavirus disease , is still in the headlines for the impressive health and economic burden worldwide. The immune response against this novel virus is still undergoing extensive research, and the possible long-term outcomes remain basically unknown. Immunity plays a key role in the defense against several microorganisms, and SARS-CoV-2 is no different. The infections can result in a hyperactive immune response with excessive inflammatory reactions. 1 These are generally accompanied by the release of impressive amounts of proinflammatory cytokines, an event known as "cytokine storm," that is correlated with lung damage, organ failure, and a negative prognosis. [2] [3] The possibility that these immunologic derangements could result in the induction and/or the exacerbation of other immune-mediated diseases, including cutaneous ones, has not been completely investigated. We report the case of a 61-year-old female patient referred to our dermatologic department for the development of asymp- A topical therapy with a high-potency steroid (clobetasol ointment) and vitamin E emollient was started, with a remarkable improvement after 8 weeks and a complete clinical resolution after 16 weeks of treatment (Fig. 1b) . Morphea, also known as localized scleroderma, is an inflammatory skin condition that is characterized by the presentation of single or multiple inflammatory or sclerotic plaques. 4 While the pathogenesis remains largely unknown, several factors can contribute to the emergence of autoimmune disease including the genetic predisposition, environmental triggers such as bacterial and viral infections, and intrinsic factors, such as hormonal and immunologic dysregulation. 5 In this case, the negative personal anamnesis for autoimmune disorders and the development of cutaneous manifestations after COVID-19 infection suggested a possible link between autoimmune disease and SARS-CoV-2. Some authors proposed that SARS-CoV-2 could act as a trigger in the development of organ-specific autoimmune disorders, in genetic predisposed subjects. 6 In particular, a molecular mimicry phenomenon between virus and human protein has been hypothesized. Hence, the exaggerated activation of immune system against the virus could induce a cross-reaction with auto-antigens in common with viral peptides, leading to an autoimmune dysfunction. 7 Recently, some authors reported the development and/or worsening of inflammatory skin diseases after COVID-19 infection, such as atopic dermatitis 8 and psoriasis, 9 induced by abnormal activation of the immune system in response to virus and consequent inflammatory pathways. To the best of our knowledge, in the literature, there are no reports of morphea triggered by COVID-19 infection. We report this case to underline the importance of this clinical condition during the COVID-19 pandemic for the dermatologists, in order to provide a proper diagnosis and a correct therapeutic management. The COVID-19 cytokine storm; what we know so far Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Localized scleroderma The viral autoimmunity relationship Covid-19 and autoimmunity Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases COVID-19-associated surge of atopic dermatitis Covid-19 and exacerbation of psoriasis The patient in this manuscript has given written informed consent.